Report of 33 Novel AVPR2 Mutations and Analysis of 117 Families with X-Linked Nephrogenic Diabetes Insipidus
Takuya Fujiwara(Montreal General Hospital), Anna K. Naumova(McGill University Health Centre), Daniel G. Bichet(Hôpital du Sacré-Cœur de Montréal), Gary L. Robertson(Northwestern University), Kenneth Morgan(University of London), Bernard S. Kaplan(Children's Hospital of Philadelphia), Denis Morin(Inserm), Luiz Armando De Marco(Universidade Federal de Minas Gerais), M. JOYCE CRUMLEY(Montreal General Hospital), Sei Sasaki(Tokyo Medical and Dental University)
Cited by 187
Related Papers
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
|Nature Genetics|1999|1.7k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823
Agalsidase-Beta Therapy for Advanced Fabry Disease
|Annals of Internal Medicine|2007|565
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555